Folate and vitamin B12 deficiency and hyperhomocysteinemia promote oxidative stress in adult type 2 diabetes

Nutrition

Volumn 28, Issue 7-8, 2012, Pages

  Al Maskari, Masoud Y ^a   Waly, Mostafa I ^a   Ali, Amanat ^a   Al Shuaibi, Yusra S ^a   Ouhtit, Allal ^a  

^a SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Folate; Homocysteine; Oxidative stress; Type 2 diabetes mellitus; Vitamin B12

Indexed keywords

CATALASE; CYANOCOBALAMIN; FOLIC ACID; GLUCOSE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; SUPEROXIDE DISMUTASE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CYANOCOBALAMIN DEFICIENCY; DIETARY INTAKE; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; FOOD FREQUENCY QUESTIONNAIRE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; OMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL ANTIOXIDANT STATUS; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

ADULT; ANTIOXIDANTS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIET; FEMALE; FOLIC ACID; FOLIC ACID DEFICIENCY; GLUTATHIONE; HOSPITALS, UNIVERSITY; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; OMAN; OUTPATIENT CLINICS, HOSPITAL; OXIDATIVE STRESS; OXIDOREDUCTASES; PREVALENCE; VITAMIN B 12; VITAMIN B 12 DEFICIENCY; YOUNG ADULT;

EID: 84862208421     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2012.01.005     Document Type: Article

References (35)

1. Shils M.E., Shike M., Ross A.C., Caballero B., Cousins R.J. Modern nutrition in health and disease 2006, Lippincott Williams & Wilkins, Philadelphia, p 550-2. 10th ed.
2. Chen N.C., Yang F., Capecci L.M., Gu Z., Schafer A.I., Durante W., et al. Regulation of homocysteine metabolism and methylation in human and mouse tissues. FASEB J 2010, 24:2804-2817.
3. Lee D.H., Jacobs D.R., Porta M. Hypothesis: a unifying mechanism for nutrition and chemicals as lifelong modulators of DNA hypomethylation. Environ Health Perspect 2009, 117:1799-1802.
4. Watson W.P., Munter T., Golding B.T. A new role for glutathione: protection of vitamin B12 from depletion by xenobiotics. Chem Res Toxicol 2004, 17:1562-1567.
5. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implications for health. J Nutr 2004, 134:489-492.
6. Carpenter D.O., Arcaro K., Spink D.C. Understanding the human health effects of chemical mixtures. Environ Health Perspect 2002, 110:25-42.
7. Al-Maskari M., Al-Shukaili A., Al-Mammari A. Pro-inflammatory cytokines in Omani type 2 diabetic patients presenting anxiety and depression. Iran J Immunol 2010, 7:124-129.
8. Hayden M.R., Tyagi S.C. Homocysteine and reactive oxygen species in metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: the pleiotropic effects of folate supplementation. Nutr J 2004, 3:4-7.
9. Fuchs D., Jaeger M., Widner B., Artner-Dworzak E., Leblhuber F. Is hyperhomocysteinemia due to oxidative depletion of folate rather than to insufficiency dietary intake?. Clin Chem Med 2001, 39:691-694.
10. Widner B., Enzinger C., Laich A., Wirleitner B., Fuchs D. Hyperhomocysteinemia, pteridines and oxidative stress. Curr Drug Metab 2002, 3:225-232.
11. Selhub J., Jacques P.F., Wilson P.W. Vitamin status and intake as primary determinant of homocystinemia in an elderly population. JAMA 1993, 270:2693-2698.
12. Selhub J., Jacques P.F., Dallal G., Choumenkovitch S., Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food Nutr Bull 2008, 29:S67-S73.
13. Selhub J., Jacques P.F., Rosenberg I.H., Rogers G., Bowman B.A., Gunter E.W., et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999, 131:331-339.
14. Savage D.G., Lindenbaum J., Stabler S.P., Allen R.H. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiencies. Am J Med 1994, 96:239-246.
15. 12) and folate deficiency. FASEB J 1993, 7:1344-1353.
16. Ng S.W., Zaghloul S., Ali H.I., Harrison G., Popkin B.M. The prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf States. Obes Rev 2011, 12:1-13.
17. Ganguly S.S., Al-Shafaee M.A., Al-Lawati J.A., Dutta P.K., Duttagupta K.K. Epidemiological transition of some diseases in Oman: a situational analysis. East Mediterr Health J 2009, 15:209-218.
18. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:160-167. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
19. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 1998, 68:899-917.
20. Willet W.C. Food frequency methods in nutritional epidemiology 1988, Oxford University Press, New York, p 74-100. 2nd ed.
21. Block G., Hartman A.M., Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology 1990, 1:58-64.
22. Pietinen P., Hartman A.M., Haapa E., Räsänen L., Haapakoski J., Palmgren J., et al. Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 1988, 128:655-666.
23. Varely H., Gowenlock A.H., Bell M. Practical clinical biochemistry 1980, Heinmann Medical Books, London, p 405-11. 5th ed.
24. Kei S., Takahiro O., Yoshimasa K. Determination of folate and vitamin B12 by ADVIA Centaur. J Anal Biosci 2006, 29:235-242.
25. Quillard M., Berthe M.C., Sauger F., Lavoinne A. Plasma determination of homocysteine on CPC Immulite 2000: comparison with determination on IMX Abbott. Ann Biol Clin 2003, 61:699-704.
26. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes: thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline 1998, National Academy Press, Washington, DC, p 196-305.
27. Frantzen F., Faaren A.L., Alfheim I., Nordhei A.K. Enzyme conversion immunoassay for determining total homocysteine in plasma or serum. Clin Chem 1998, 44:311-316.
28. Brouwer I.A., van Dusseldrop M., Thomas C.M., Duran M., Hautvast J.G.A.J., Eskes T.K.A.B., et al. Low dose folic acid supplementation decrease plasma homocysteine concentration: a randomized trial. Indian Heart J 2000, 52:S53-S58.
29. Tice JA, Rose E, Coxson PG, Rosenberg I, Weinstein MC, Hunink MG, et al. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease. Effect of grain fortification and beyond. JAMA;286:936-43.
30. Michiels C., Raes M., Toussaint O., Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 1994, 17:235-248.
31. Nouroz-Zadeh J., Rahimi A., Tajaddini-Samadi J., Tritschler H., Rosen P., Halliwell B., Betteridge D.J. Relationship between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 1997, 40:647-653.
32. Sözmen E.Y., Sözmen B., Delen Y.Y., Onat T. Catalase/superoxide dismutase (SOD) and catalase/paraoxonase (PON) ratio may implicate poor glycemic control. Arch Med Res 2001, 32:283-287.
33. Likidlilid A., Patchanans N., Peerapatdit T., Sriratanasathavorn C. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai 2010, 93:682-693.
34. Siemianowicz K., Gminski J., Telega A., Wójcik A., Posielezna B., Grabowska-Bochenek R., Francuz T. Blood antioxidant parameters in patients with diabetic retinopathy. Int J Mol Med 2004, 14:433-437.
35. Kesavulu M.M., Rao B.K., Giri R., Vijaya J., Subramanyam G., Apparao C. Lipid peroxidation and antioxidant enzyme status in type 2 diabetics with coronary heart disease. Diabetes Res Clin Pract 2001, 53:33-39.